Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 7
2007 3
2008 11
2009 13
2010 17
2011 13
2012 18
2013 13
2014 10
2015 9
2016 5
2017 7
2018 14
2019 14
2020 14
2021 15
2022 16
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Results by year

Filters applied: . Clear all
Page 1
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.
Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Svatek RS, Mashni J Jr, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown G, Canter D, Luchey A, Lotan Y, Krupski T, Inman BA, Williams MB, Cookson MS, Keegan KA, Andriole GL Jr, Sankin AI, Boyd A, O'Donnell MA, Sawutz D, Philipson R, Coll R, Narayan VM, Treasure FP, Yla-Herttuala S, Parker NR, Dinney CPN. Boorjian SA, et al. Among authors: svatek rs. Lancet Oncol. 2021 Jan;22(1):107-117. doi: 10.1016/S1470-2045(20)30540-4. Epub 2020 Nov 27. Lancet Oncol. 2021. PMID: 33253641 Free PMC article. Clinical Trial.
Identification of Differential Tumor Subtypes of T1 Bladder Cancer.
Robertson AG, Groeneveld CS, Jordan B, Lin X, McLaughlin KA, Das A, Fall LA, Fantini D, Taxter TJ, Mogil LS, Lindskrog SV, Dyrskjøt L, McConkey DJ, Svatek RS, de Reyniès A, Castro MAA, Meeks JJ. Robertson AG, et al. Among authors: svatek rs. Eur Urol. 2020 Oct;78(4):533-537. doi: 10.1016/j.eururo.2020.06.048. Epub 2020 Jul 17. Eur Urol. 2020. PMID: 32684305
Reply by Authors.
Garg H, Psutka SP, Hakimi AA, Kim HL, Mansour AM, Pruthi DK, Liss MA, Wang H, Gaspard CS, Ramamurthy C, Svatek RS, Kaushik D. Garg H, et al. Among authors: svatek rs. J Urol. 2022 Sep;208(3):560. doi: 10.1097/JU.0000000000002829.04. Epub 2022 Sep 1. J Urol. 2022. PMID: 35942787 No abstract available.
Reply by Authors.
Garg H, Psutka SP, Hakimi AA, Kim HL, Mansour AM, Pruthi DK, Liss MA, Wang H, Gaspard CS, Ramamurthy C, Svatek RS, Kaushik D. Garg H, et al. Among authors: svatek rs. J Urol. 2022 Sep;208(3):559. doi: 10.1097/JU.0000000000002829.02. Epub 2022 Sep 1. J Urol. 2022. PMID: 35942785 No abstract available.
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial.
Parekh DJ, Reis IM, Castle EP, Gonzalgo ML, Woods ME, Svatek RS, Weizer AZ, Konety BR, Tollefson M, Krupski TL, Smith ND, Shabsigh A, Barocas DA, Quek ML, Dash A, Kibel AS, Shemanski L, Pruthi RS, Montgomery JS, Weight CJ, Sharp DS, Chang SS, Cookson MS, Gupta GN, Gorbonos A, Uchio EM, Skinner E, Venkatramani V, Soodana-Prakash N, Kendrick K, Smith JA Jr, Thompson IM. Parekh DJ, et al. Among authors: svatek rs. Lancet. 2018 Jun 23;391(10139):2525-2536. doi: 10.1016/S0140-6736(18)30996-6. Lancet. 2018. PMID: 29976469 Clinical Trial.
Reply by Authors.
de Jong JJ, Liu Y, Boorjian SA, Bivalacqua TJ, Porten SP, Wheeler T, Davicioni E, Svatek RS, Boormans JL, Black PC, Lotan Y, Gibb EA. de Jong JJ, et al. Among authors: svatek rs. J Urol. 2020 Aug;204(2):246. doi: 10.1097/JU.0000000000000798.03. Epub 2020 May 27. J Urol. 2020. PMID: 32459975 No abstract available.
Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical Trial.
Messing EM, Tangen CM, Lerner SP, Sahasrabudhe DM, Koppie TM, Wood DP Jr, Mack PC, Svatek RS, Evans CP, Hafez KS, Culkin DJ, Brand TC, Karsh LI, Holzbeierlein JM, Wilson SS, Wu G, Plets M, Vogelzang NJ, Thompson IM Jr. Messing EM, et al. Among authors: svatek rs. JAMA. 2018 May 8;319(18):1880-1888. doi: 10.1001/jama.2018.4657. JAMA. 2018. PMID: 29801011 Free PMC article. Clinical Trial.
Editorial Comment.
Svatek RS. Svatek RS. J Urol. 2018 Jun;199(6):1451. doi: 10.1016/j.juro.2017.12.077. Epub 2018 Mar 12. J Urol. 2018. PMID: 29545192 No abstract available.
162 results